Fields »
ABOUT
HELP
BLOG

347 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 7 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
VAMP8Vesicle-associated membrane protein 8Predicted intracellular proteins
Predicted membrane proteins
Transporters
Thyroid cancer: 8.07e-9
Urothelial cancer: 1.59e-6
Expressed in all
ROR2Receptor tyrosine kinase-like orphan receptor 2Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Thyroid cancer: 4.28e-8
Renal cancer: 9.86e-7
Tissue enhanced
PRKAB2Protein kinase, AMP-activated, beta 2 non-catalytic subunitPredicted intracellular proteins
NucleoplasmThyroid cancer: 6.78e-7
Breast cancer: 4.55e-4
Head and neck cancer: 7.32e-4
Expressed in all
SNAI1Snail family zinc finger 1Predicted intracellular proteins
Transcription factors
Nucleus
Cytosol		Renal cancer: 2.63e-7
Thyroid cancer: 8.82e-7
Lung cancer: 1.61e-5
Colorectal cancer: 4.76e-4
Tissue enhanced
FIBINFin bud initiation factor homolog (zebrafish)Predicted secreted proteins
Thyroid cancer: 1.85e-6
Renal cancer: 1.93e-5
Stomach cancer: 6.72e-4
Tissue enhanced
HECTD3HECT domain containing E3 ubiquitin protein ligase 3Predicted intracellular proteins
Thyroid cancer: 1.85e-6
Liver cancer: 2.14e-5
Expressed in all
PDLIM3PDZ and LIM domain 3Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 4.97e-7
Thyroid cancer: 2.13e-6
Liver cancer: 7.22e-4
Tissue enhanced
TRIM21Tripartite motif containing 21Plasma proteins
Predicted intracellular proteins
NucleoplasmThyroid cancer: 2.26e-6
Breast cancer: 4.83e-5
Liver cancer: 1.87e-4
Expressed in all
COPZ2Coatomer protein complex, subunit zeta 2Predicted intracellular proteins
Renal cancer: 3.45e-9
Thyroid cancer: 2.89e-6
Urothelial cancer: 4.66e-4
Mixed
GLTPGlycolipid transfer proteinPredicted intracellular proteins
CytosolThyroid cancer: 4.17e-6
Cervical cancer: 2.01e-5
Liver cancer: 7.68e-4
Expressed in all
FAM171A1Family with sequence similarity 171, member A1Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane		Thyroid cancer: 4.90e-6
Renal cancer: 2.71e-5
Mixed
SYNDIG1Synapse differentiation inducing 1Predicted membrane proteins
VesiclesThyroid cancer: 6.16e-6
Tissue enhanced
TUBB4BTubulin, beta 4B class IVbFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MicrotubulesThyroid cancer: 6.36e-6
Endometrial cancer: 4.91e-4
Liver cancer: 9.98e-4
Expressed in all
MYL12BMyosin, light chain 12B, regulatoryPlasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center		Thyroid cancer: 6.62e-6
Renal cancer: 8.17e-5
Pancreatic cancer: 9.69e-4
Expressed in all
CCND3Cyclin D3Cancer-related genes
Predicted intracellular proteins
Plasma membrane
Focal adhesion sites
Cytosol		Thyroid cancer: 8.08e-6
Expressed in all
RAB34RAB34, member RAS oncogene familyPredicted intracellular proteins
Renal cancer: 1.64e-7
Thyroid cancer: 1.06e-5
Expressed in all
MAP1AMicrotubule-associated protein 1AFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolThyroid cancer: 1.09e-5
Urothelial cancer: 1.66e-5
Renal cancer: 6.59e-5
Tissue enriched
INPP1Inositol polyphosphate-1-phosphataseEnzymes
Predicted intracellular proteins
Vesicles
Microtubule organizing center		Thyroid cancer: 1.12e-5
Urothelial cancer: 5.70e-4
Expressed in all
GAS1Growth arrest-specific 1Cancer-related genes
Predicted secreted proteins
Nuclear specklesThyroid cancer: 1.13e-5
Renal cancer: 1.96e-5
Colorectal cancer: 1.55e-4
Stomach cancer: 8.26e-4
Tissue enhanced
ALDH1B1Aldehyde dehydrogenase 1 family, member B1Enzymes
Predicted intracellular proteins
Nucleoplasm
Vesicles
Mitochondria		Thyroid cancer: 1.17e-5
Renal cancer: 2.05e-4
Expressed in all
ANTXR1Anthrax toxin receptor 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesThyroid cancer: 1.22e-5
Cervical cancer: 5.76e-4
Mixed
KIAA1211LKIAA1211-likePredicted intracellular proteins
Microtubules
Cytokinetic bridge
Centrosome		Renal cancer: 1.13e-5
Thyroid cancer: 1.33e-5
Tissue enhanced
WDR37WD repeat domain 37Predicted intracellular proteins
Intermediate filaments
Centrosome
Cytosol		Pancreatic cancer: 1.46e-6
Thyroid cancer: 1.34e-5
Head and neck cancer: 1.75e-5
Expressed in all
GUF1GUF1 homolog, GTPasePredicted intracellular proteins
Nucleus
Mitochondria		Renal cancer: 2.66e-6
Thyroid cancer: 1.65e-5
Mixed
TSHZ1Teashirt zinc finger homeobox 1Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmThyroid cancer: 1.71e-5
Expressed in all
UBE2Q1Ubiquitin-conjugating enzyme E2Q family member 1Enzymes
Predicted intracellular proteins
Nucleoplasm
Centrosome		Renal cancer: 4.84e-7
Thyroid cancer: 1.86e-5
Liver cancer: 8.74e-4
Expressed in all
CALM2Calmodulin 2 (phosphorylase kinase, delta)Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Transporters
Thyroid cancer: 1.94e-5
Liver cancer: 8.35e-5
Endometrial cancer: 4.84e-4
Breast cancer: 5.05e-4
Expressed in all
CILPCartilage intermediate layer protein, nucleotide pyrophosphohydrolaseDisease related genes
Predicted secreted proteins
Thyroid cancer: 2.24e-5
Tissue enhanced
TRIM16LTripartite motif containing 16-likePredicted intracellular proteins
Plasma membrane
Cytosol		Thyroid cancer: 2.29e-5
Liver cancer: 2.87e-4
Mixed
RINT1RAD50 interactor 1Predicted intracellular proteins
Golgi apparatusThyroid cancer: 2.39e-5
Expressed in all
PLA2G16Phospholipase A2, group XVIEnzymes
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
MitochondriaPancreatic cancer: 5.58e-6
Thyroid cancer: 2.54e-5
Expressed in all
SENP6SUMO1/sentrin specific peptidase 6Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol		Thyroid cancer: 2.83e-5
Renal cancer: 6.09e-4
Expressed in all
MCM3Minichromosome maintenance complex component 3Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
NucleoplasmThyroid cancer: 3.13e-5
Melanoma: 4.40e-5
Liver cancer: 1.40e-4
Cervical cancer: 1.89e-4
Expressed in all
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneRenal cancer: 1.40e-6
Thyroid cancer: 3.19e-5
Endometrial cancer: 6.00e-5
Ovarian cancer: 2.67e-4
Glioma: 6.07e-4
Tissue enhanced
PAPSS23'-phosphoadenosine 5'-phosphosulfate synthase 2Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaMelanoma: 1.33e-6
Thyroid cancer: 3.21e-5
Pancreatic cancer: 6.58e-4
Expressed in all
BCKDHABranched chain keto acid dehydrogenase E1, alpha polypeptideDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Renal cancer: 5.33e-10
Thyroid cancer: 3.27e-5
Head and neck cancer: 9.37e-4
Expressed in all
C14orf119Chromosome 14 open reading frame 119Predicted intracellular proteins
Mitochondria
Cytosol		Thyroid cancer: 3.30e-5
Liver cancer: 5.42e-5
Expressed in all
ZCCHC12Zinc finger, CCHC domain containing 12Predicted intracellular proteins
Nuclear bodiesThyroid cancer: 3.42e-5
Group enriched
FKBP10FK506 binding protein 10, 65 kDaDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
VesiclesRenal cancer: 0.00e+0
Thyroid cancer: 3.43e-5
Cervical cancer: 4.16e-4
Urothelial cancer: 4.99e-4
Mixed
SLC37A1Solute carrier family 37 (glucose-6-phosphate transporter), member 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
NucleusThyroid cancer: 3.43e-5
Endometrial cancer: 9.22e-5
Mixed
FGF1Fibroblast growth factor 1 (acidic)Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmRenal cancer: 2.59e-5
Thyroid cancer: 3.45e-5
Tissue enhanced
ZC4H2Zinc finger, C4H2 domain containingDisease related genes
Predicted intracellular proteins
Vesicles
Microtubules		Thyroid cancer: 3.51e-5
Mixed
DERADeoxyribose-phosphate aldolase (putative)Enzymes
Predicted intracellular proteins
NucleusThyroid cancer: 3.64e-5
Pancreatic cancer: 1.32e-4
Expressed in all
CNFNCornifelinPredicted intracellular proteins
Microtubules
Cytokinetic bridge		Thyroid cancer: 4.02e-5
Group enriched
MRPS18AMitochondrial ribosomal protein S18APredicted intracellular proteins
Ribosomal proteins
Thyroid cancer: 4.03e-5
Expressed in all
TPT1Tumor protein, translationally-controlled 1Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 2.54e-5
Thyroid cancer: 4.31e-5
Breast cancer: 5.90e-5
Endometrial cancer: 2.35e-4
Expressed in all
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol		Urothelial cancer: 6.19e-6
Thyroid cancer: 4.57e-5
Endometrial cancer: 5.71e-5
Tissue enriched
RNF181Ring finger protein 181Predicted intracellular proteins
Nucleoplasm
Cytosol		Renal cancer: 1.06e-6
Thyroid cancer: 4.59e-5
Expressed in all
PRDM16PR domain containing 16Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmThyroid cancer: 4.70e-5
Mixed
DRAP1DR1-associated protein 1 (negative cofactor 2 alpha)Predicted intracellular proteins
CytosolRenal cancer: 3.73e-5
Thyroid cancer: 4.96e-5
Expressed in all

Page of 7 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.